BALCHEM CORP (BCPC)
Materials · Specialty chemicals and nutritional ingredients · NASDAQ
Balchem is a specialty chemicals and nutrition ingredients manufacturer serving human nutrition, animal feed, food systems, and industrial sterilization markets with microencapsulation and chelation technologies.
What BALCHEM CORP does
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, plant nutrition, sterilization, fumigation, and industrial markets. The company operates three main segments: Human Nutrition and Health (choline nutrients, mineral amino acid chelates, vitamin K2, microencapsulation solutions, and food/beverage ingredient systems), Animal Nutrition and Health (choline chloride, microencapsulated nutrients, and chelated products for animal feed), and Specialty Products (performance gases and chemicals including ethylene oxide and propylene oxide).
Themes: ["Human nutrition / dietary supplements","Animal feed additives / livestock nutrition","Food and beverage ingredient systems","Microencapsulation technology","Specialty chemicals / sterilization gases"]
Fundamentals
- Price$163.53 as of 2026-07-09 close
- Market cap$5.2B as of 2026-07-10
- 1-year return+0.6% as of 2026-07-09 close
- P/E33.14 as of 2026-07-10
- Net margin+14.9% as of 2026-07-10
- Gross margin+36.3% as of 2026-07-10
- ROE+12.4% as of 2026-07-10
- Debt / equity0.13 as of 2026-07-10
- Revenue growth (YoY)+9.6% as of 2026-07-10
- Revenue CAGR (3y)+3.2% SEC XBRL
- Beta0.82 as of 2026-07-10
Dividend: yield +0.6%; 4-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Commodity-based choline chloride segment exposed to global price volatility and intense competition requiring sustained cost efficiency and quality reputation to maintain competitive position","Dependence on regulatory approvals and acceptance of microencapsulation and chelation technologies in food, pharmaceutical, and animal health applications, which may limit market expansion","Foreign currency translation exposure evident from Q1 2026 $10.1 million other comprehensive loss, creating earnings volatility from international operations"]
Competitors & peers
- DSM-Firmenich (DSMN)
- Kemin Industries
- Adisseo (China Zhouyuan)
- Evonik Industries
- BASF SE
- Corbion
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.